We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Boyd Gaming
BYD
$6.27B
| $4.79M | ﹤0.01% |
79,168
-7,940
| -9% | -$501K |
|
2077
PUT
DexCom
DXCM
$31.2B
| $4.78M | ﹤0.01% |
44,800
-56,400
| -56% | -$5.42M |
|
2078
Design Therapeutics
DSGN
$832M
| $4.78M | ﹤0.01% |
240,158
+178,730
| +291% | +$4.51M |
|
2079
Vanguard FTSE Europe ETF
VGK
$31.1B
| $4.78M | ﹤0.01% |
71,003
-142,642
| -67% | -$9.63M |
|
2080
PUT
APA Corp
APA
$12.4B
| $4.76M | ﹤0.01% |
220,200
+177,300
| +413% | +$3.64M |
|
2081
Cirrus Logic
CRUS
$6.57B
| $4.76M | ﹤0.01% |
55,961
-10,840
| -16% | -$869K |
|
2082
Synaptics
SYNA
$3.93B
| $4.76M | ﹤0.01% |
30,612
+866
| +3% | +$117K |
|
2083
Helen of Troy
HELE
$673M
| $4.76M | ﹤0.01% |
20,876
-145
| -0.7% | -$31.9K |
|
|
PXD
2084
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
| $4.76M | ﹤0.01% |
+30,000
| New | +$4.71M |
|
2085
PUT
Sarepta Therapeutics
SRPT
$1.73B
| $4.76M | ﹤0.01% |
61,200
-4,800
| -7% | -$364K |
|
2086
CALL
Aptiv
APTV
$9.86B
| $4.75M | ﹤0.01% |
30,000
-30,000
| -50% | -$4.4M |
|
|
HUYA
2087
Huya Inc
HUYA
$570M
| $4.75M | ﹤0.01% |
269,036
-60,601
| -18% | -$1.02M |
|
2088
Integra LifeSciences
IART
$1.38B
| $4.74M | ﹤0.01% |
69,476
-10,508
| -13% | -$743K |
|
2089
CALL
First Solar
FSLR
$25.3B
| $4.72M | ﹤0.01% |
52,200
| – | – |
|
2090
ICU Medical
ICUI
$4.18B
| $4.72M | ﹤0.01% |
22,928
-4,769
| -17% | -$981K |
|
2091
PUT
Conagra Brands
CAG
$7.16B
| $4.71M | ﹤0.01% |
+131,100
| New | +$4.91M |
|
2092
PUT
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$150M
| $4.71M | ﹤0.01% |
+10,000
| New | +$5.96M |
|
2093
Valley National Bancorp
VLY
$8.16B
| $4.71M | ﹤0.01% |
350,799
+5,115
| +1% | +$71.4K |
|
|
OZON
2094
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $4.71M | ﹤0.01% |
80,312
-6,028
| -7% | -$351K |
|
2095
nVent Electric
NVT
$26.6B
| $4.7M | ﹤0.01% |
153,232
-35,847
| -19% | -$1.1M |
|
2096
Valmont Industries
VMI
$9.72B
| $4.7M | ﹤0.01% |
20,402
-3,306
| -14% | -$800K |
|
|
ELME
2097
Elme Communities
ELME
$145M
| $4.67M | ﹤0.01% |
205,087
+3,516
| +2% | +$82.7K |
|
2098
PUT
SPDR Gold Trust
GLD
$137B
| $4.67M | ﹤0.01% |
28,200
-485,100
| -95% | -$82.4M |
|
2099
Textron
TXT
$15.2B
| $4.67M | ﹤0.01% |
69,100
-3,641
| -5% | -$235K |
|
2100
Rayonier
RYN
$6.56B
| $4.66M | ﹤0.01% |
143,740
-31,426
| -18% | -$1.03M |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.